These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 19407253)

  • 41. Role of soluble guanylyl cyclase-cyclic GMP signaling in tumor cell proliferation.
    Mujoo K; Sharin VG; Martin E; Choi BK; Sloan C; Nikonoff LE; Kots AY; Murad F
    Nitric Oxide; 2010 Jan; 22(1):43-50. PubMed ID: 19948239
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Altered guanylyl-cyclase activity in vitro of pulmonary arteries from fetal lambs with congenital diaphragmatic hernia.
    Thébaud B; Petit T; De Lagausie P; Dall'Ava-Santucci J; Mercier JC; Dinh-Xuan AT
    Am J Respir Cell Mol Biol; 2002 Jul; 27(1):42-7. PubMed ID: 12091244
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Altered vascular function in fetal programming of hypertension.
    Lamireau D; Nuyt AM; Hou X; Bernier S; Beauchamp M; Gobeil F; Lahaie I; Varma DR; Chemtob S
    Stroke; 2002 Dec; 33(12):2992-8. PubMed ID: 12468802
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nitric oxide decreases stability of mRNAs encoding soluble guanylate cyclase subunits in rat pulmonary artery smooth muscle cells.
    Filippov G; Bloch DB; Bloch KD
    J Clin Invest; 1997 Aug; 100(4):942-8. PubMed ID: 9259594
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endothelium-derived NO, but not cyclic GMP, is required for hypoxic augmentation in isolated porcine coronary arteries.
    Chan CK; Mak J; Gao Y; Man RY; Vanhoutte PM
    Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2313-21. PubMed ID: 21984543
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nitric oxide-soluble guanylyl cyclase signaling regulates corticostriatal transmission and short-term synaptic plasticity of striatal projection neurons recorded in vivo.
    Sammut S; Threlfell S; West AR
    Neuropharmacology; 2010 Mar; 58(3):624-31. PubMed ID: 19969007
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The soluble guanylyl cyclase inhibitor NS-2028 reduces vascular endothelial growth factor-induced angiogenesis and permeability.
    Morbidelli L; Pyriochou A; Filippi S; Vasileiadis I; Roussos C; Zhou Z; Loutrari H; Waltenberger J; Stössel A; Giannis A; Ziche M; Papapetropoulos A
    Am J Physiol Regul Integr Comp Physiol; 2010 Mar; 298(3):R824-32. PubMed ID: 20032260
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity.
    Galle J; Zabel U; Hübner U; Hatzelmann A; Wagner B; Wanner C; Schmidt HH
    Br J Pharmacol; 1999 May; 127(1):195-203. PubMed ID: 10369473
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Involvement of soluble guanylate cyclase alpha(1) and alpha(2), and SK(Ca) channels in NANC relaxation of mouse distal colon.
    Dhaese I; Vanneste G; Sips P; Buys E; Brouckaert P; Lefebvre RA
    Eur J Pharmacol; 2008 Jul; 589(1-3):251-9. PubMed ID: 18572161
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of a novel inhibitor of guanylyl cyclase on dilator responses of mouse cerebral arterioles.
    Sobey CG; Faraci FM
    Stroke; 1997 Apr; 28(4):837-42; discussion 842-3. PubMed ID: 9099205
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vivo microdialysis study of a specific inhibitor of soluble guanylyl cyclase on the glutamate receptor/nitric oxide/cyclic GMP pathway.
    Fedele E; Jin Y; Varnier G; Raiteri M
    Br J Pharmacol; 1996 Oct; 119(3):590-4. PubMed ID: 8894183
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3-alpha]quinoxalin-1-one (ODQ) inhibits relaxation of rabbit aortic rings induced by carbon monoxide, nitric oxide, and glyceryl trinitrate.
    Hussain AS; Marks GS; Brien JF; Nakatsu K
    Can J Physiol Pharmacol; 1997 Aug; 75(8):1034-7. PubMed ID: 9360020
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intrathecal cGMP elicits pressor responses and maintains mean blood pressure during haemorrhage in anaesthetized rats.
    Malik V; Holobotovskyy VV; Phillips JK; McKitrick DJ; Arnolda LF
    J Physiol; 2007 Jun; 581(Pt 2):543-52. PubMed ID: 17347277
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of cGMP hydrolysing phosphodiesterases 1 and 5 in cerebral artery dilatation.
    Kruuse C; Rybalkin SD; Khurana TS; Jansen-Olesen I; Olesen J; Edvinsson L
    Eur J Pharmacol; 2001 May; 420(1):55-65. PubMed ID: 11412839
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impaired iNOS-sGC-cGMP signalling contributes to chronic hypoxic and hypercapnic pulmonary hypertension in rat.
    Xia XD; Xu ZJ; Hu XG; Wu CY; Dai YR; Yang L
    Cell Biochem Funct; 2012 Jun; 30(4):279-85. PubMed ID: 22290599
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase.
    Olesen SP; Drejer J; Axelsson O; Moldt P; Bang L; Nielsen-Kudsk JE; Busse R; Mülsch A
    Br J Pharmacol; 1998 Jan; 123(2):299-309. PubMed ID: 9489619
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of soluble guanylate cyclase inhibition on inflammation and motility disturbances in DSS-induced colitis.
    Van Crombruggen K; Van Nassauw L; Demetter P; Cuvelier C; Timmermans JP; Lefebvre RA
    Eur J Pharmacol; 2008 Jan; 579(1-3):337-49. PubMed ID: 18022154
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Soluble guanylyl cyclase is a target of angiotensin II-induced nitrosative stress in a hypertensive rat model.
    Crassous PA; Couloubaly S; Huang C; Zhou Z; Baskaran P; Kim DD; Papapetropoulos A; Fioramonti X; Durán WN; Beuve A
    Am J Physiol Heart Circ Physiol; 2012 Sep; 303(5):H597-604. PubMed ID: 22730391
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Age-dependent modulation of endothelium-dependent vasodilatation by chronic hypoxia in ovine cranial arteries.
    Williams JM; Pearce WJ
    J Appl Physiol (1985); 2006 Jan; 100(1):225-32. PubMed ID: 16179402
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Escherichia coli lipopolysaccharide downregulates soluble guanylate cyclase in pulmonary artery smooth muscle.
    Scott WS; Nakayama DK
    J Surg Res; 1998 Dec; 80(2):309-14. PubMed ID: 9878330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.